Company profile: Quantgene
1.1 - Company Overview
Company description
- Provider of genomics and AI solutions in cancer diagnostics and liquid biopsy.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quantgene
Toyobo
HQ: United States
Website
- Description: Provider of life science products in Japan for research and industrial fields, including KOD DNA Polymerase with proofreading/high elongation for PCR; ReverTra Ace M-MLV reverse transcriptase for efficient cDNA synthesis; MagExtractor kits with magnetic silica beads for nucleic acid extraction; THUNDERBIRD qPCR mix for SYBR Green I; GenNext NGS library prep for Illumina; and one-step RT-PCR Quick Master Mix using Tth DNA polymerase.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Toyobo company profile →
Caris Life Sciences
HQ: United States
Website
- Description: Provider of molecular profiling and AI-driven precision oncology solutions, offering tissue-based profiling, specimen testing services to identify molecular cancer characteristics for personalized treatment, shipper kits for specimen transport, and billing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caris Life Sciences company profile →
Celmatix
HQ: United States
Website
- Description: Provider of preclinical discovery and development focused on women’s ovarian health, including target identification and validation for endometriosis, PCOS, and ovarian senescence; collaborative discovery, development, and commercialization with Evotec and Bayer; contraceptive target discovery supported by the Bill & Melinda Gates Foundation; and proprietary cohorts, annotations, and NLP-driven research tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celmatix company profile →
Cobra Biologics
HQ: United Kingdom
Website
- Description: Provider of contract manufacturing for biologics and pharmaceuticals for pre-clinical, clinical, and commercial supply. An international CMO with three GMP-approved facilities in Sweden and the UK, offering expertise tailored to customers worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cobra Biologics company profile →
DNA Script
HQ: France
Website
- Description: Provider of enzymatic DNA synthesis solutions, featuring the SYNTAX benchtop DNA printer for on-demand custom oligo production up to 120 nucleotides using Enzymatic DNA Synthesis (EDS). Offers SYNTAX 96 Hi-Fidelity and 96 Standard kits for 96 oligos (up to 120 nt or 80 nt), the SYNTAX 192 Label Kit for probes with up to two labels for qPCR and FISH, and SYNTAX Labels including fluorophores, quenchers, and biotin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DNA Script company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quantgene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quantgene
2.2 - Growth funds investing in similar companies to Quantgene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quantgene
4.2 - Public trading comparable groups for Quantgene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →